Pro Logo
Get Adobe Flash player

Promedica Inc. Acquired by Cello Group plc

Burlingame, Calif., December 9, 2014 -- Promedica, Inc., a full-service healthcare market research firm today announced that it has been acquired by Cello Group plc (AIM: CLL), a leading global healthcare and consumer strategic marketing group based in London. Promedica will become part of Cello Health and its global specialist capabilities in consulting, insight and communications.

Promedica specializes in new product planning for life sciences companies. The firm has earned its reputation over three decades as a trusted advisor to healthcare companies by providing custom primary research and market intelligence to help support commercial success. Based in the San Francisco Bay Area, Promedica has particular expertise in biotechnology and helping companies evaluate and commercialize new, innovative products to improve patients' lives.

The acquisition of Promedica aligns with Cello's US expansion strategy, and strengthens its footprint in biotechnology. Stephen Highley, Chairman of Cello Health said "Our acquisition of this talented and experienced team fits with our expansion strategy in the US and opens up opportunities for growth on the west coast where we are seeing significant activity and potential in biotech and related areas."

The Cello acquisition is an extension of Promedica's strategic focus on providing high value, high impact information through insightful primary market research. "We are delighted to join the Cello Health family and become part of a larger organization offering our clients the benefit of a broad and deep global network of healthcare expertise," said Joan Day, President of Promedica.

In reflecting on the additional resources now available, Susan Rowen, Executive Vice President of Promedica said "We are pleased to continue to provide our clients with the same service and support we always have, as well as expand capabilities within the Cello organization."

About Promedica, Inc.
Promedica, Inc, is a full-service market research consulting firm specializing in new product planning for life sciences companies. As an advisor to biotech, pharma, diagnostics firms, start-ups and the investment community, the company helps inform critical decisions and mitigate risk through custom primary market research and thought partnership. Promedica Inc. is based in Burlingame, California.  For more information visit

About Cello Health
Cello Health comprises 3 capabilities: Cello Health Insight, Cello Health Consulting and Cello Health Communications.  Services range from early product commercialization, strategy and research to how we build and communicate evidence and understand the emerging impact of patient choice.  Cello Health offers clients depth via its specialized capabilities and also the ability to solve our clients' greatest challenges through a truly unified approach that looks through different lenses to unlock the potential of assets, brands, and organizations.  Cello Health is a global organization that operates from offices in New York, Philadelphia, Chicago, San Francisco, London and other locations in the UK and Europe.  More information at

Back to Newsroom

© 2018 Worldwide Promedica. Inc.